News/Reacta Healthcare Receives Extended MHRA Pharmac
GlobeNewswireUnresolved

Reacta Healthcare Receives Extended MHRA Pharmaceutical Manufacturer’s Licence and GMP Certificate

DEESIDE, United Kingdom, June 10, 2026 (GLOBE NEWSWIRE) -- Reacta Healthcare, a leading developer and manufacturer of pharmaceutical-grade oral food challenge (OFC) products for food allergy diagnostics, today announces the renewal and extension of its Manufacturer’s Licence and GMP Certificate by the UK Government’s Medicines & Healthcare products Regulatory Agency (MHRA).

Reacta Healthcare Receives Extended MHRA Pharmaceutical Manufacturer’s Licence and GMP Certificate